1. Organoruthenium complexes with benzo-fused pyrithiones overcome platinum resistance in ovarian cancer cellsJerneja Kladnik, James P. C. Coverdale, Jakob Kljun, Hilke Burmeister, Petra Lippman, Francesca G. Ellis, Alan M. Jones, Ingo Ott, Isolda Romero-Canelón, Iztok Turel, 2021, original scientific article Keywords: ruthenium, pyrithione, resistance to chemotherapy, cancer, ovarian, thioredoxin Full text (file, 3,10 MB) This document has more files! More... |
|
3. The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancerDavid Lukanovič, Maruša Herzog, Borut Kobal, Katarina Černe, 2020, review article Keywords: gyneacology, ovarian cancer, chemoresistance, predictive marker, ATP7A, ATP7B Full text (file, 1,68 MB) This document has more files! More... |
4. Metabolism of estrogensStefan Poschner, Judith Wackerlig, Dan Cacsire Castillo-Tong, Andrea Wolf, Isabel von der Decken, Tea Lanišnik-Rižner, Renata Pavlič, Anastasia Meshcheryakova, Diana Mechtcheriakova, Monika Fritzer-Szekeres, Theresia Thalhammer, Walter Jäger, 2020, original scientific article Keywords: high-grade serous ovarian cancer, steroid hormones, metabolomics, LC-HRMS, carboplatin resistance, interleukin-6 Full text (file, 2,70 MB) This document has more files! More... |
|
6. Application of dynamic and static light scattering for size and shape characterization of small extracellular nanoparticles in plasma and ascites of ovarian cancer patientsKsenija Kogej, Darja Božič, Borut Kobal, Maruša Herzog, Katarina Černe, 2021, original scientific article Keywords: extracellular vesicles, extracellular nanoparticles, ovarian cancer, dynamic light scattering, static light scattering, particle size, particle shape Full text (file, 1,98 MB) This document has more files! More... |
7. Overview of immune checkpoint inhibitors in gynecological cancer treatmentBoštjan Pirš, Erik Škof, Vladimir Smrkolj, Špela Smrkolj, 2022, review article Keywords: immune check-point inhibitor, biomarker, endometrial cancer, ovarian cancer, uterine cervical cancer, vulvar cancer, treatment response prediction Full text (file, 731,71 KB) This document has more files! More... |
8. AKR1B1 as a prognostic biomarker of high-grade serous ovarian cancerMarko Hojnik, Nataša Kenda Šuster, Špela Smrkolj, Damjan Sisinger, Snježana Frković-Grazio, Ivan Verdenik, Tea Lanišnik-Rižner, 2022, original scientific article Keywords: high-grade serous ovarian cancer, immunohistochemistry, survival, prognosis, biomarker, aldo-keto reductase family 1 member B1 (AKR1B1), aldo-keto reductase family 1 member B10 (AKR1B10), resistance Full text (file, 6,42 MB) This document has more files! More... |
9. Physiological concentrations of Cimicifuga racemosa extract do not affect expression of genes involved in estrogen biosynthesis and action in endometrial and ovarian cell linesMaša Sinreih, Klara Gregorič, Kristina Gajser, Tea Lanišnik-Rižner, 2022, original scientific article Keywords: endometrial cancer, Cimicifuga racemosa, ovarian cancer, steroid transporters Full text (file, 5,66 MB) This document has more files! More... |
10. A dual biomarker TK1 protein and CA125 or HE4-based algorithm as a better diagnostic tool than ROMA Index in early detection of ovarian cancerDiana Cviič, K. K. Jagarlamudi, Leon Meglič, Erik Škof, Andrej Zore, David Lukanovič, Staffan Eriksson, Joško Osredkar, 2023, original scientific article Keywords: thymidine kinase 1, TK 210 ELISA, TK-liaison, CA 125, HE4, ROMA index, ovarian cancer Full text (file, 3,69 MB) This document has more files! More... |